Operator: Thank you for standing by and welcome to the Natera Inc. Q3 Earnings Conference Call. All lines have been placed on mute to prevent any background noise.
/PRNewswire/ Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced full enrollment for the RenaCARE (Renasight Clinical.
(BPT) - Did you know chronic kidney disease (CKD) affects an estimated 37 million adults in the United States? Even more surprising, 90% of people in early stage CKD are unaware that they have the disease, according to the Centers for Disease Control a.